Good to connect with Diana Spencer to discuss the critical unmet need for Long COVID Fatigue treatments, and to explain the mechanism of action for Axcella Therapeutics’ investigational product for Long COVID Fatigue, AXA1125. Read her piece for Drug Discovery World here: https://lnkd.in/e2mDyS3U.
Senior Digital Content Editor, Drug Discovery World; Sub-editor, Bite Magazine
1yThanks for chatting to us about this important and pertinent topic. Looking forward to seeing how AXA1125 progresses!